Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: Incidence, correlations and prognostic utility

Anticancer Research

Volumn 32, Issue 4, 2012, Pages 1273-1281

  Stoyianni, Aikaterini ^a,e   Goussia, Anna ^a   Pentheroudakis, George ^a,b   Siozopoulou, Vassiliki ^a   Ioachim, Elli ^f   Krikelis, Dimitrios ^a,c   Golfinopoulos, Vassilios ^a   Cervantes, Andres ^d   Bobos, Mattheos ^c   Fotsis, Theodoros ^e   Bellou, Sofia ^e   Fountzilas, Georgios ^b,c   Malamou Mitsi, Vassiliki ^a   Pavlidis, Nicholas ^a,b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b Hellenic Cooperative Oncology Group   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d UNIVERSITY OF VALENCIA   (Spain)

^e Institute of Biomedical Research   (Greece)

^f Xatzikosta General Hospital   (Greece)

Author keywords

Cancer of unknown primary; E Cadherin; Epithelial mesenchymal transition; Immunohistochemistry; N cadherin; NOTCH1; OCT4; SNAIL; Vimentin

Indexed keywords

NERVE CELL ADHESION MOLECULE; PLATINUM; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER OF UNKNOWN PRIMARY SITE; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STAINING; TISSUE MICROARRAY; TUMOR CELL; UNDIFFERENTIATED CARCINOMA; VISCERAL METASTASIS;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; OCTAMER TRANSCRIPTION FACTOR-3; PHENOTYPE; PROGNOSIS; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS; VIMENTIN;

EID: 84860006878     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Pavlidis N and Fizazi K: Cancer of unknown primary (CUP). Crit Rev Oncol Hematol 54(3): 243-250, 2005. (Pubitemid 40693686)
2. Pavlidis N, Briasoulis E, Hainsworth J and Greco FA: Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 40(9): 1454-1445, 2004.
3. Geiger TR and Peeper DS: Metastasis mechanisms. Biochim Et Biophys Acta 1796: 293-308, 2009.
4. Polyak K and Weinberg RA: Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9(4): 265-273, 2009.
5. Micalizzi DS, Farabaugh SM and Ford HL: Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 15(2): 117-134, 2010.
6. Thiery JP: Epithelial mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15(6): 740-746, 2003.
7. Kondo M, Wagers AJ, Manz MG, Prohaska SS, Scherer DC, Beilhack GF, Shizuru JA and Weissman IL: Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol 21: 759-806, 2003. (Pubitemid 37174547)
8. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M and Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics: Reporting recommendations for tumor marker prognostic studies. J Clin Oncol 23: 9067-9072, 2005.
9. Thiery JP: Epithelial mesenchymal transitions in tumour progression. Nat Rev Cancer 2(6): 442-454, 2002.
10. Fountzilas G, Kourea HP, Bobos M, Televantou D, Kotoula V, Papadimitriou C, Papazisis KT, Timotheadou E, Efstratiou I, Koutras A, Pentheroudakis G, Christodoulou C, Aravantinos G, Miliaras D, Petraki K, Papandreou CN, Papakostas P, Bafaloukos D, Repana D, Razis E, Pectasides D and Dimopoulos AM: Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker evaluation. Anticancer Res 31(9): 3007-3018, 2011.
11. Gotzmann J, Mikula M, Eger A, Schulte-Hermann R, Foisner R, Beug H and Mikulits W: Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat Res 566(1): 9-20, 2004. (Pubitemid 38045586)
12. Jiao W, Miyazaki K and Kitajima Y: Inverse correlation between E-cadherin and SNAIL expression in hepatocellular carcinoma cell lines in vitro and in vivo. Br J Cancer 86(1): 98-101, 2002. (Pubitemid 34146348)
13. Rosivatz E, Becker KF, Kremmer E, Schott C, Blechschmidt K, Höfler H and Sarbia M: Expression and nuclear localization of SNAIL, an E-cadherin repressor, in adenocarcinomas of the upper gastrointestinal tract. Virchows Arch 448(3): 277-287, 2006. (Pubitemid 43357643)
14. Roy HK, Smyrk TC, Koetsier J, Victor TA and Wali RK: The transcriptional repressor SNAIL is overexpressed in human colon cancer. Dig Dis Sci 50(1): 42-46, 2005. (Pubitemid 40385032)
15. Christofori G: New signals from the invasive front. Nature 441(7092): 444-450, 2006.
16. Moody SE, Perez D, Pan TC, Pan TC, Sarkisian CJ, Portocarrero CP, Sterner CJ, Notorfrancesco KL, Cardiff RD and Chodosh LA: The transcriptional repressor SNAIL promotes mammary tumor recurrence. Cancer Cell 8(3): 197-209, 2005. (Pubitemid 41317591)
17. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J and Weinberg RA: The epithelial mesenchymal transition generates cells with properties of stem cells. Cell 133(4): 704-715, 2008. (Pubitemid 351636299)
18. Bao B, Wang Z, Ali S, Kong D, Li Y, Ahmad A, Banerjee S, Azmi AS, Miele L and Sarkar FH: Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Lett 307(1): 26-36, 2011.
19. Takebe N, Warren RQ and Ivy SP: Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition. Breast Cancer Res 13(3): 211, 2011.
20. Martin TA, Goyal A, Watkins G and Jiang WG: Expression of the transcription factors SNAIL, SLUG, and TWIST and their clinical significance in human breast cancer. Ann Surg Oncol 12(6): 488-496, 2005. (Pubitemid 40884264)
21. Elloul S, Elstrand MB, Nesland JM, Tropé CG, Kvalheim G, Goldberg I, Reich R and Davidson B: SNAIL, SLUG and SMUG-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer 103(8): 1631-1643, 2005. (Pubitemid 40490024)
22. Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M and Hung MC: Dual regulation of SNAIL by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6(10): 931-940, 2004. (Pubitemid 39359846)
23. Côme C, Magnino F, Bibeau F, De Santa Barbara P, Becker KF, Theillet C and Savagner P: SNAIL and SLUG play distinct roles during breast carcinoma progression. Clin Can Res 12(18): 5395-5402, 2006. (Pubitemid 44497253)
24. Liang X: EMT: new signals from the invasive front. Oral Oncol 47(8): 686-687, 2011.
25. Bryne M, Boysen M, Alfsen CG, Abeler VM, Sudbø J, Nesland JM, Kristensen GB, Piffko J and Bankfalvi A: The invasive front of carcinomas. The most important area for tumour prognosis? Anticancer Res 18(6B): 4757-4764, 1998. (Pubitemid 29042056)
26. Hüsemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, Forni G, Eils R, Fehm T, Riethmüller G and Klein CA: Systemic spread is an early step in breast cancer. Cancer Cell 13(1): 58-68, 2008. (Pubitemid 350309740)